Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Gildan Activewear Inc. (NYSE: GIL) and Lead Plaintiff Deadline on December 14, 2026

A securities class action alleges Gildan lacked adequate internal controls and used channel stuffing to create the appearance of revenue; the claims remain allegations. Jehoshaphat Research, which disclosed a short position, alleged Gildan pulled forward about $500 million of revenue. Gildan shares fell $11.63, or 18.7%, to $50.34 on June 16, 2026, after the report; investors have until December 14, 2026, to seek lead-plaintiff status.

Analysis

The material risk is not the class-action filing itself; it is whether the underlying channel-stuffing allegation is corroborated by filings and cash conversion. If customers received product earlier than end demand justified, the reversal can hit later-period sales while elevated receivables, returns or discounting pressure cash flow and gross margin. That would weaken the durability of earnings and could matter more to valuation than litigation damages. The short seller’s estimate is an allegation, not an independently established revenue adjustment.

Near term, the June selloff may have already priced in a substantial part of the concern; without the current share price and subsequent disclosures, this November notice alone does not establish attractive short entry. The December 14 lead-plaintiff deadline is a procedural date, not a reliable fundamental catalyst. Over 1–3 months, monitor quarterly receivables growth versus sales, days sales outstanding, operating cash flow versus earnings, returns/allowances, and any auditor or control disclosures. Over 6–18 months, a confirmed sell-in/sell-through mismatch could force revenue-quality reassessment and create discounting spillovers for apparel basics competitors, including Hanesbrands and Fruit of the Loom; the magnitude is unproven.

Contrarian read: litigation notices often amplify an already-public short thesis without adding evidence. A clean reconciliation of receivables and cash conversion, with no revisions or control findings, would undercut the bear case. A restatement, auditor concern, or deteriorating collections would materially strengthen it.

Key Decisions for Investors

• Do not initiate a directional position solely on this legal notice. Treat it as an alert to verify Gildan’s post-June disclosures and current valuation before acting.
• For an existing long, size exposure against the accounting downside and review the next report for receivables growth relative to sales, cash conversion, and returns/allowances; reduce risk if those indicators worsen or management revises prior figures.
• Consider a defined-risk bearish position only if filings corroborate deteriorating collections or revenue-quality concerns; prefer waiting for that evidence over chasing the previously reported one-day decline. Falsifiers: stable or improving days sales outstanding, operating cash flow tracking earnings, and no control, auditor, or revenue revisions.
• Track the December 14 lead-plaintiff deadline as a procedural milestone, not a standalone trading catalyst. Escalate the thesis only on independently verifiable evidence such as a restatement, auditor warning, regulatory action, or materially weaker cash conversion.